CULTURED AFB ANTITUBERCULAR DST RAPID 5 SECOND LINE DRUGS PANEL Test
Test Name: CULTURED AFB ANTITUBERCULAR DST RAPID 5 SECOND LINE DRUGS PANEL Test
Components: Ofloxacin, Levofloxacin, Moxifloxacin, PAS, Cycloserine
Price: 1350.0 AED
Sample Condition: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.
Report Delivery: Sample Daily by 3.30 pm; Report 21 days
Method: Automated Fluorescent
Test type: Tuberculosis
Doctor: Physician
Test Department:
Pre Test Information: No special preparation required
Test Details
The Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test is a diagnostic test used to determine the drug susceptibility of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). This test specifically focuses on detecting resistance to second-line drugs, which are used when the first-line drugs are ineffective or the patient has developed resistance.
The test involves culturing the bacteria in a laboratory setting and exposing it to a panel of five second-line drugs commonly used in TB treatment. These drugs include fluoroquinolones (such as levofloxacin and moxifloxacin), injectable drugs (such as kanamycin and amikacin), and a drug called capreomycin. After exposure to these drugs, the test measures the growth of the bacteria to determine if they are susceptible or resistant to the drugs.
This information helps healthcare providers tailor the most effective treatment regimen for patients with drug-resistant TB. Overall, the Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test plays a crucial role in guiding treatment decisions for patients with drug-resistant TB, ensuring they receive the most appropriate and effective medications to combat the infection.
Test Name | CULTURED AFB ANTITUBERCULAR DST RAPID 5 SECOND LINE DRUGS PANEL Test |
---|---|
Components | *Ofloxacin*Levofloxacin*Moxifloxacin*PAS*Cycloserine |
Price | 1350.0 AED |
Sample Condition | Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity. |
Report Delivery | Sample Daily by 3.30 pm;Report 21 days |
Method | Automated Fluorescent |
Test type | Tuberculosis |
Doctor | Physician |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test is a diagnostic test used to determine the drug susceptibility of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). This test specifically focuses on detecting resistance to second-line drugs, which are used when the first-line drugs are ineffective or the patient has developed resistance. The test involves culturing the bacteria in a laboratory setting and exposing it to a panel of five second-line drugs commonly used in TB treatment. These drugs include fluoroquinolones (such as levofloxacin and moxifloxacin), injectable drugs (such as kanamycin and amikacin), and a drug called capreomycin. After exposure to these drugs, the test measures the growth of the bacteria to determine if they are susceptible or resistant to the drugs. This information helps healthcare providers tailor the most effective treatment regimen for patients with drug-resistant TB. Overall, the Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test plays a crucial role in guiding treatment decisions for patients with drug-resistant TB, ensuring they receive the most appropriate and effective medications to combat the infection. |